Anticancer Bioscience Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Anticancer Bioscience General Information

Description

Developer of precision therapeutics designed for synthetic lethal cancer therapies. The company utilises artificial intelligence drug discovery, mechanism-informed phenotypic screening, a synthetic lethal approach, small-molecule drug discovery, natural product drug discovery, and lead optimisation, providing the healthcare sector with biomarker-driven cancer therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Chengdu Tianfu International Bio-city
  • Chengdu, Sichuan 610219
  • China
+86 028
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Chengdu Tianfu International Bio-city
  • Chengdu, Sichuan 610219
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anticancer Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 31-Dec-2025 Completed Generating Revenue
3. Later Stage VC 26-Sep-2021 Completed Generating Revenue
2. Early Stage VC 08-Feb-2021 $9.7M $20.4M Completed Generating Revenue
1. Seed Round $10.6M $10.6M Completed Startup
To view Anticancer Bioscience’s complete valuation and funding history, request access »

Anticancer Bioscience Patents

Anticancer Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260175276-A1 Sheet metal drawing machine Pending 20-Dec-2024
EP-4763372-A1 Sheet metal stretch forming machine Pending 20-Dec-2024
FR-3170355-A1 Sheet metal stretch forming machine Pending 20-Dec-2024
FR-3060425-A1 Longitudinal stretch shape forming machine Active 19-Dec-2016
FR-3060425-B1 Longitudinal stretch shape forming machine Inactive 19-Dec-2016 B21D25/00
To view Anticancer Bioscience’s complete patent history, request access »

Anticancer Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anticancer Bioscience Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
CY Capital Venture Capital Minority
Dunhong Capital Management PE/Buyout Minority
To view Anticancer Bioscience’s complete investors history, request access »

Anticancer Bioscience FAQs

  • When was Anticancer Bioscience founded?

    Anticancer Bioscience was founded in 2016.

  • Where is Anticancer Bioscience headquartered?

    Anticancer Bioscience is headquartered in Chengdu, China.

  • What is the size of Anticancer Bioscience?

    Anticancer Bioscience has 50 total employees.

  • What industry is Anticancer Bioscience in?

    Anticancer Bioscience’s primary industry is Drug Discovery.

  • Is Anticancer Bioscience a private or public company?

    Anticancer Bioscience is a Private company.

  • What is Anticancer Bioscience’s current revenue?

    The current revenue for Anticancer Bioscience is .

  • How much funding has Anticancer Bioscience raised over time?

    Anticancer Bioscience has raised $31M.

  • Who are Anticancer Bioscience’s investors?

    CY Capital and Dunhong Capital Management have invested in Anticancer Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process